 3. Female participants of childbearing potential must agree for the duration of the study and for a period of at least 1 month following the last dose of perampanel to be abstinent or to commit to the consistent and correct use of a medically acceptable method of birth control eg, a double-barrier method condom plus spermicide, condom plus diaphragm with spermicide. 